Sadly i think its more like 20p a share but i havec10k shares so be happy with that , but if yuour £5 prediction came in 
Your not alone on this one should have waited longer, but like wise will hold and see what happens fingers crossed
I’m hoping for a gradual turnaround
17k shares. @0.06 This is bombing so hard.
I am not sure how to average down, maybe I should watch some videos on it.
Is it just buy more cheap?
Thank you.
Dreaming about a home deposit. 
Let’s see where this gets to. I think I am just going to hold.
Forgive my ignorance but does what happened in Australia stocks affect London stocks when it comes to articles like above?
Yikes, under 4p today.
I’m really feeling the burn at -27%
Yep im struggling at -22% but just got to hang in and believe 
2 Likes
Bought more at 3.9p to bring my average down… now to hold for long term and hope for the best I think.
1 Like
Very true. Don’t buy more than you’re willing to lose, these are high risk stocks for sure. I’m just treating this as a bet that one of them will have a good increase within the next 5 years, rather than the more traditional investments I have elsewhere…
I feel like I made a mistake buying these in a GIA, in case they increase in value a lot over time.
I think if it came to that you would just sell your shares in the GIA then transfer the cash directly to your ISA.
1 Like
Is this company in trouble in ASX?
LSE share chat goes about it.
Trying to a small amount of this stock but it keeps getting rejected?
I am down 35% and falling. It doesn’t make good reading but holding for the long term and hoping it will bounce back in the next year or two
2 Likes
Wonder what’s going on across the pond hmmmm
They’re flocking from the Australian exchange.
I’d steer clear of the comments. Do your own research and make your own decisions. Don’t let these comments sway you to making a decision, you bought into MGC for a reason in the first place.
We’re going to see lots of red days, this for me is a 2-3 year hold minimum.
3 Likes
And this is why you don’t just use things like SWS for analysis. If you look at their half year report you will find:
*They still have over $9m undrawn from their finance facility.
*They completed their UK IPO after the period which raised another $11.7m, which was supported by many institutional investors.
*They are projected to more than double revenue next year.
*Despite lower revenue this year their gross profit increased over 50% and their operating loss halved YoY.
This is obviously risky, but there will always be bad actors that know they can manipulate such a small float, especially when it involves the patience of investors.
My 2¢, DYOR everyone
8 Likes
It’s understandable but on directors in last year’s report management renumeration was $1.2m and revenue $2m. If you add the rights management were granted it’s over and I agree with the frustration of some investors at such high costs, but basic compensation is lower than it was in 2019.
Also I think now know why revenue is lower last half. If you look carefully pharmaceutical revenue was actually up massively YoY (134k to 741k), but last year around $1m of revenue from raw cannabidiol sales were recognised in the first half but this might be quite lumpy. It’s a five year agreement but should become less and less meaningful and pharma revenues become much more important. Here’s a short writeup on it:
1 Like